Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Lyso-thermosensitive Liposomal Doxorubicin (LTLD, ThermoDox®) and Magnetic Resonance-Guided High Intensity Focused Ultrasound (MR-HIFU) for Treatment of Relapsed or Refractory Solid Tumors

NCT04791228 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT04791228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04791228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Lyso-thermosensitive Liposomal Doxorubicin (LTLD, ThermoDox®) and Magnetic Resonance-Guided High Intensity Focused Ultrasound (MR-HIFU) for Treatment of Relapsed or Refractory Solid Tumors
Lead sponsor
Children's National Research Institute
Phase
Phase 2
Overall status
Withdrawn
Start date
November 10, 2022
Completion date
December 23, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, ewing sarcoma, germ cell tumor, hepatic tumor, malignant epithelial neoplasm, rhabdomyosarcoma, soft tissue sarcoma, solid tumors, wilms tumor